Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9753 USD | +0.28% | +4.87% | -10.52% |
05-21 | Lineage Cell Therapeutics, Inc. Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium | CI |
05-09 | Transcript : Lineage Cell Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.52% | 184M | |
+55.70% | 59.34B | |
+42.49% | 40.24B | |
-5.39% | 39.88B | |
-5.56% | 28.55B | |
+16.46% | 27.26B | |
-20.56% | 19.23B | |
+33.03% | 12.61B | |
+25.85% | 12.28B | |
+2.72% | 12.49B |
- Stock Market
- Equities
- LCTX Stock
- News Lineage Cell Therapeutics, Inc.
- BioTime, Inc. Appoints Chase C. Leavitt as General Counsel and Corporate Secretary